We expect an expanding customer base, stringent cost control and strategic acquisitions to drive G's results in the long term.
Does Genpact (G) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
G's third-quarter 2024 earnings and revenues increase on a year-over-year basis.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Genpact Limited (NYSE:G ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Krista Bessinger - Head of Investor Relations Balkrishan Kalra - President and Chief Executive Officer Mike Weiner - Chief Financial Officer Conference Call Participants Jared Levine - TD Cowen Maggie Nolan - William Blair Robbie Bamberger - Baird Surinder Thind - Jefferies Bradley Clark - BMO Capital Markets Operator Good day, ladies and gentlemen. Welcome to the 2024 Third Quarter Genpact Limited Earnings Conference Call.
Genpact (G) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.76 per share a year ago.
Genpact (G) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Broadridge Financial Solutions, Genpact and ExlService have been highlighted in this Industry Outlook article.
Genpact (G) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Genpact's new 3+1 Execution Framework and external tailwinds are driving improved performance and competitive advantages. Its Q2-2024 results exceeded revenue and EPS estimates, showcasing strong financial health and a dividend yield of 1.58%. Despite industry competition, Genpact's valuation metrics and potential for capital gains support a Buy rating, with a total return expectation of 10.58%.